The SENS Research Foundation is at the forefront of rejuvenation technology. The practice, which many organizations like SENS are trying to build into an industry, seeks innovative ways to combat aging. Life-threatening and life-altering conditions that arise from aging impact everyone. Slowly but surely everyone gets older and succumbs to the deterioration such a conditions brings. The anti-aging movement exits to find ways to slow it down, stop it, and prevent it all together. Over the past decades SENS has funded many revolutionary treatments to combat cancer. Cancer, as well as Parkinson’s, and Alzheimer’s, are diseases that come as a result of aging. SENS exists from the backing of private researchers, scientists, and investors passionate about refining rejuvenation technology. One such advocate is Jason Hope, who in 2010 donated half-a-million dollars to the organization.
Jason Hope is an entrepreneur, investor, and philanthropist operating out of Scottsdale, Arizona. A graduate of the W.P. Carey School of Business with an MBA from Arizona State University. He is an expert in all facets of business, and provides advisement for students and fellow entrepreneurs alike. Through his success he has been able to turn to philanthropy and donate money to causes he stands behind. Rejuvenation technology is a big one. Hope is always posting the latest innovations on social media, and writing articles for his specific interests in magazines. He is one of many wealthy entrepreneurs advocating time and funds for anti-aging, a cause that becomes a more passionate topic the older such investors become. Entrepreneur Jason Hope Invests in Research Against Aging
Aubrey De Grey, who co-founded SENS and remains its chief science officer, claims investments by backers such as hope are the life-blood of the anti-aging business. The company used Hope’s donation to build the Cambridge SENS Laboratory, as well as start new research initiatives. Hope initially donated money to the company because of their work developing treatments for degenerative diseases. Currently the organization is focused on AGE metabolic waste, tissue that builds up within the body leading to degenerative processes. Through its research the company hopes to develop treatments that fight AGE waste, which could significantly fight Alzheimer’s, osteoporosis, and arthritis.